ALEMBIC Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC have increased by 40.89% YoY .
The Earnings Per Share (EPS) of ALEMBIC has increased by 15.68 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ALEMBIC Last 5 Annual Financial Results
[BOM: 506235|NSE : ALEMBICLTD]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹222 Cr | ₹157 Cr | ₹127 Cr | ₹78 Cr | ₹74 Cr |
| Expenses | ₹128 Cr | ₹101 Cr | ₹87 Cr | ₹64 Cr | ₹63 Cr |
| Operating Profit (Excl OI) | ₹94 Cr | ₹57 Cr | ₹40 Cr | ₹14 Cr | ₹10 Cr |
| Other Income | ₹75 Cr | ₹55 Cr | ₹64 Cr | ₹89 Cr | ₹11 Cr |
| Interest | ₹2.47 Cr | ₹1.11 Cr | ₹0.47 Cr | ₹0.39 Cr | ₹0.36 Cr |
| Depreciation | ₹11 Cr | ₹7.84 Cr | ₹6.72 Cr | ₹4.86 Cr | ₹3.94 Cr |
| Profit Before Tax | ₹156 Cr | ₹103 Cr | ₹87 Cr | ₹98 Cr | ₹17 Cr |
| Profit After Tax | ₹145 Cr | ₹93 Cr | ₹81 Cr | ₹86 Cr | ₹14 Cr |
| Consolidated Net Profit | ₹311 Cr | ₹269 Cr | ₹191 Cr | ₹222 Cr | ₹343 Cr |
| Earnings Per Share (Rs) | ₹12.10 | ₹10.46 | ₹7.42 | ₹8.65 | ₹13.35 |
| PAT Margin (%) | 65.16 | 58.97 | 63.36 | 110.20 | 18.83 |
| ROE(%) | 6.39 | 4.36 | 3.52 | 3.60 | 0.75 |
| ROCE(%) | 6.95 | 4.86 | 3.82 | 4.10 | 0.94 |
| Total Debt/Equity(x) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 2,580.3 Cr |
| Revenue (TTM) | : | ₹ 220.9 Cr |
| Net Profit(TTM) | : | ₹ 145.0 Cr |
| EPS (TTM) | : | ₹ 5.6 |
| P/E (TTM) | : | 17.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC | 0.5% | -3.8% | -20.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 4.2% | -10.9% |
| DIVIS LABORATORIES | -0.5% | 8.9% | 10.8% |
| CIPLA | 0.4% | 3.7% | 8% |
| TORRENT PHARMACEUTICALS | -0% | -2.1% | 6.6% |
| DR REDDYS LABORATORIES | 2.2% | -1.8% | -4.4% |
| MANKIND PHARMA | -1.9% | -5.1% | -7.3% |
| ZYDUS LIFESCIENCES | 1.9% | -3.8% | 0.3% |
| LUPIN | -0.4% | -3.7% | -9.7% |
ALEMBIC Revenues
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 40.89 % |
| 5 Yr CAGR | 31.81 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹222 Cr | 40.89 | |
| Mar2024 | ₹157 Cr | 23.77 | |
| Mar2023 | ₹127 Cr | 62.68 | |
| Mar2022 | ₹78 Cr | 6.40 | |
| Mar2021 | ₹74 Cr | - | |
ALEMBIC Operating Profit
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 64.80 % |
| 5 Yr CAGR | 73.14 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹94 Cr | 64.80 | |
| Mar2024 | ₹57 Cr | 40.98 | |
| Mar2023 | ₹40 Cr | 189.55 | |
| Mar2022 | ₹14 Cr | 33.59 | |
| Mar2021 | ₹10 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 16.95 % |
| 5 Yr CAGR | 31.37 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 42.23% | 16.95 | |
| Mar2024 | 36.11% | 13.91 | |
| Mar2023 | 31.7% | 77.99 | |
| Mar2022 | 17.81% | 25.60 | |
| Mar2021 | 14.18% | - | |
ALEMBIC Profit After Tax
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 15.66 % |
| 5 Yr CAGR | -2.43 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹311 Cr | 15.66 | |
| Mar2024 | ₹269 Cr | 40.90 | |
| Mar2023 | ₹191 Cr | -14.14 | |
| Mar2022 | ₹222 Cr | -35.23 | |
| Mar2021 | ₹343 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 10.50 % |
| 5 Yr CAGR | 36.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 65.16 % | 10.50 | |
| Mar2024 | 58.97 % | -6.93 | |
| Mar2023 | 63.36 % | -42.50 | |
| Mar2022 | 110.2 % | 485.24 | |
| Mar2021 | 18.83 % | - | |
ALEMBIC Earnings Per Share (EPS)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 15.68 % |
| 5 Yr CAGR | -2.43 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 | 15.68 | |
| Mar2024 | ₹10 | 40.97 | |
| Mar2023 | ₹7.42 | -14.22 | |
| Mar2022 | ₹8.65 | -35.21 | |
| Mar2021 | ₹13 | - | |
ALEMBIC Return on Capital Employed (ROCE)
[BOM: 506235|NSE : ALEMBICLTD]
| Y-o-Y | 43.00 % |
| 5 Yr CAGR | 64.90 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 6.95% | 43.00 | |
| Mar2024 | 4.86% | 27.23 | |
| Mar2023 | 3.82% | -6.83 | |
| Mar2022 | 4.1% | 336.17 | |
| Mar2021 | 0.94% | - | |
ALEMBIC Share Price vs Sensex
| Current Share Price | : | ₹100.5 |
| Current MarketCap | : | ₹ 2,580.3 Cr |
| Updated EOD on | : | Oct 24,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | 0.5% |
-3.8% |
-20.7% |
| SENSEX | 0.9% |
2.5% |
3.7% |
ALEMBIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | 0.4% | -1.3% | -5.3% |
| BSE CONSUMER DISCRETIONARY & SERVICES | -0.2% | -1.5% | -3% |
No NSE index found
You may also like the below Video Courses
FAQ about ALEMBIC Financials
How the annual revenues of ALEMBIC have changed ?
The Revenues of ALEMBIC have increased by 40.89% YoY .
How the Earnings per Share (EPS) of ALEMBIC have changed?
The Earnings Per Share (EPS) of ALEMBIC has increased by 15.68 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC
Compare Stock Analytics of Peers of ALEMBIC
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
